British Journal of Haematology · 2000 · 11 citations · 3 references
MedicineHematologyOncologyHematologic OncologyTransfusion MedicineTransplant ImmunologyGraft-versus-host DiseaseLymphoid NeoplasmsTransfusion ReactionsTransfusion SupportTransplant ComplicationsTransplant-related ToxicitiesBlood Product IrradiationDonor-recipient Immunologic RiskIrradiation Of Blood ComponentsIrradiation Of Blood ProductsNon-hodgkin Lymphoma TherapyNon-hodgkin Lymphoma TreatmentTransfusion-associated Graft-versus-host Disease
We present the case of a 64-year-old man who died from transfusion-associated graft vs. host disease (TA-GVHD) having been treated 2 years earlier for a high-grade, non-Hodgkin's lymphoma (NHL). We suggest that he was at increased risk of developing TA-GVHD as a result of the NHL and its subsequent treatment, and propose that patients with NHL should be added to those 'at risk' groups who receive irradiated cellular blood components.
3
Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports
L. M. Williamson, Sarina C. Lowe, Elizabeth M. Love et al. · BMJ · 1999 · 339 citations · Full text